The knee reconstruction devices market is on track for substantial growth, with a projected market valuation of USD 8.5 billion by 2023. According to Future Market Insights (FMI), the market is anticipated to expand at a moderate Compound Annual Growth Rate (CAGR) of 4.3% from 2023 to 2033, reaching approximately USD 13.0 billion by the end of 2033.
According to Future Market Insights (FMI), the rapid expansion of the knee reconstruction devices market can be attributed to significant innovations in product design and functionality. Market participants are reaping the benefits of the increasing prevalence of knee-related ailments, such as arthritis and knee discomfort, which drive the demand for advanced knee reconstruction solutions.
Request Your Detailed Report Sample With Your Work Email:
https://www.futuremarketinsights.com/reports/sample/rep-gb-4878
One of the key developments in the market for knee reconstruction devices is the requirement for the progress of less invasive surgical techniques and materials. These developments aim to improve patient outcomes, reduce surgical complications, and shorten recovery times. Additionally, the industry is witnessing an increase in funding for patient-specific knee implants and robotics-assisted surgery, which enhance precision and customization in knee reconstruction procedures.
As the world’s population ages and leads more active lives, the market for knee reconstruction devices is predicted to grow, offering a significant opportunity for the medical device sector. When everything is said and done, the market for knee reconstruction devices should grow steadily as it continues to evolve in response to patient needs and the changing landscape of healthcare.
Key Takeaways:
- The global market is estimated to capture a valuation of US$ 13.0 billion with a CAGR of 4.3% by 2033.
- In the historical period, the global market captured a CAGR of 2.8% between 2018 and 2022.
- The United States is estimated to dominate the global market by capturing a share of 29.5% by 2033.
- Germany is estimated to register a share of 8.1% in the global market during the forecast period.
- Japan is predicted to secure a share of 5.0% in the global market during the forecast period.
- With a CAGR of 4.4%, Australia is anticipated to drive the global market by 2033.
Competitive Landscape for the Knee Reconstruction Devices Market
There is a moderate market concentration in the knee reconstruction devices industry worldwide, with a few companies expected to account for most sales. Market leaders are putting more resources into Research and Development to create innovative products and gain approval from regulators more quickly to increase their knee reconstruction devices’ market share.
Recent Developments
As part of their work on a digital surgery platform that uses linked technologies, Johnson & Johnson Medical Devices Company (J&JMD) announced in January 2021 that the FDA had granted permission for their VELYS Robotic-assisted solution for use with their Attune Total Knee System.
Active Technologies received FDA clearance in March 2021 for its Citrespline and Citrelock ligament reconstruction devices, intended to prevent soft tissue damage during insertion. These devices can be used for reconstructive procedures on various joints, including the knee.
Furthermore, Conformis Inc. stated that its patient-specific iTotal PS total knee replacement system had been approved by the Therapeutic Goods Administration in Australia. This technology is intended to provide patients with reconstructive processes unique to their bodies.
Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-4878
Key Companies Profiled:
- Zimmer, Inc.
- Stryker Corporation
- DePuy Synthes
- Smith & Nephew
- Corin
- United Orthopedic Corporation
- Arthrex Inc.
- Exactech Inc.
- DJO Global
- Japan Medical Dynamic Marketing
- Tornier Inc.
Knee Reconstruction Devices Market by Segmentation:
By Product:
- Cemented Implants
- Cementless Implants
- Partial Implants
- Revision Implants
By End User:
- Hospitals
- Orthopedic Clinics
- ASCs
By Indication:
- Osteoarthritis
- Rheumatoid Arthritis
- Trauma
- Others
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East & Africa (MEA)
Explore Full Market Analysis Overview: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/4878
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube